Head-to-head · WeighScore
Carocare Wellness vs Obu Health
The verdict
Obu Health takes it — 59.7/100 to 57.9/100, but only just.
Obu Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Obu Health is a Las Vegas-based multi-product telehealth platform offering compounded semaglutide from $190/month and compounded tirzepatide from $239/month, plus NAD+ and sermorelin add-ons. Carocare Wellness is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Carocare Wellness | Obu Health |
|---|---|---|
| WeighScore | 57.9/100 | 59.7/100 |
| Grade | C | C |
| Scorecard rank | #386 | #336 |
| Semaglutide | $170/mo (compounded) | $190/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $200/mo (compounded) | $239/mo (starting dose, plus a separate fee, compounded) |
| Coverage | 1 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #386 · C
Strengths
- Real, named local clinic in Houston with hands-on provider support, in-person visits and Google-reviewed patient experiences
- Low entry pricing — semaglutide from $170 and tirzepatide from $200 in month 1, with 3-month bundles ($500 / $600) that cut the effective monthly cost
- Packages include ongoing provider support, supplies and delivery
- Also offers IV hydration and NAD+ if you want broader wellness services in one place
Where it loses points
- Houston/Texas only — no nationwide telehealth, so it is not an option outside the local area
- Dose-escalating pricing climbs steeply (semaglutide reaches $330 by month 5; tirzepatide $425 by month 6)
- Compounding pharmacy is not named, and there is no LegitScript or published clinical-oversight detail
- Small single-location operation with no patient portal — booking and support run through Calendly and direct contact
- Compounded semaglutide and tirzepatide only — no brand-name or oral options
Graded #336 · C
Strengths
- LegitScript-certified with publicly displayed ID (44206977)
- Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
- Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
- Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
- 24-hour US board-certified physician response window
Where it loses points
- Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
- No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
- Medical director not named publicly
- No published consultation fee disclosure — unclear whether physician visit is included in medication price
- All sales final per FAQ ('Federal and State law do not allow medication returns')
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.